Appeal No. 2003-0480 Page 4 Application No. 08/090245 Claim 87 will stand or fall together with claim 86. Claims 89 and 90 will stand or fall together with claim 88. 37 CFR § 1.192(c)(7). DISCUSSION “The test for obviousness is not express suggestion of the claimed invention in any or all of the references but rather what the references taken collectively would suggest to those of ordinary skill in the art presumed to be familiar with them.” In re Rosselet, 347 F.2d 847, 851, 146 USPQ 183, 186 (CCPA 1965). According to the examiner (Answer, page 4), Schochetman discloses “a method for the preparation and use of [catalytic] monoclonal antibodies as convenient, readily obtainable and inexpensive catalysts having a degree of specificity and efficiency of action not previously achievable in the catalytic arts….” While Schochetman does not disclose a catalytic antibody immobilized on a surface of, or on a surface associated with, a sensing means, the examiner emphasizes (Answer, page 5), Schochetman discloses “[i]n addition to solution phase and emulsion reaction systems, suitable conditions also include the use of support materials to which the monoclonal antibody is attached. Such support materials are well-known to those of ordinary skill in the art as are methods for attaching monoclonal antibodies to them….” The examiner relies on Schenck and Conover (id.), as “representative of the state of the art of enzyme sensors and antibody sensors at the time of the invention.” According to the examiner (Answer, bridging paragraph, pages 5-6), Schenck discloses a field effect transistor which senses and measures the binding of a substrate to an antibody which isPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007